Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates
about
A systematic study of glycopeptide esterification for the semi-quantitative determination of sialylation in antibodies.Factors influencing magnitude and duration of target inhibition following antibody therapy: implications in drug discovery and development.A novel 'pipeline' system for downstream preparation of therapeutic monoclonal antibodies.Evolving patterns in a collaboration network of global R&D on monoclonal antibodies.Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
P2860
Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@ast
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@en
type
label
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@ast
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@en
prefLabel
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@ast
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@en
P2093
P2860
P356
P1476
Bridging the gap: facilities a ...... age therapeutic mAb candidates
@en
P2093
David Y Chin
Edwin P Huang
Peter P Gray
Stephen M Mahler
P2860
P304
P356
10.4161/MABS.3.5.16968
P577
2011-09-01T00:00:00Z